Delivery Order SPE2DX22D0129-SPE2D826F0BDK
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,716.30 to AmerisourceBergen Drug Corp on November 9, 2025, with completion scheduled for November 10, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The company, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $980,600.53 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,779.39 to AmerisourceBergen Drug Corp on June 2, 2025, with completion scheduled for June 3, 2025. This is a firm fixed price, non-set-aside contract under which AmerisourceBergen will provide pharmaceutical products and medical supplies to support federal healthcare operations. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 10, 2025. The contract is a firm fixed-price delivery order with a ceiling value of $1,363.11 and an ultimate completion date of November 12, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $12,185.65 to AmerisourceBergen Drug Corp on September 29, 2025, with a completion deadline of September 30, 2025. This non-set-aside, firm fixed-price delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order represents a...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,439.51 to AmerisourceBergen Drug Corp on August 26, 2025, with completion scheduled for August 27, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract covers pharmaceutical and medical supply...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $15,443.12 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion through December 2026. The award was made on a non-set-aside, competitive basis to...
- The Defense Logistics Agency's Medical Supply Chain awarded a $15,708.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order represents a single pharmaceutical or...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp on August 5, 2025, for pharmaceutical products and medical supplies. This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at the...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0BDKDelivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,277.24 to AmerisourceBergen Drug Corp on November 10, 2025, for pharmaceutical and medical supply products. This firm fixed-price delivery order, which is due for completion by November 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. The award was competitively procured with no set-aside designation and leverages the vendor's comprehensive pharmaceutical distribution capabilities to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving military and veteran healthcare systems through its existing portfolio of federal contracts. The company supplies an extensive range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through the SPE2DX prime vendor global contract, AmerisourceBergen provides critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, enabling the DLA to fulfill diverse medical supply requirements across military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 11/10/25 |